{"AllianceGenome": "7371", "HGNC": "7371", "MIM": "601051", "_id": "10232", "_version": 1, "accession": {"genomic": ["AE006464.1", "AL031258.12", "CH471112.2", "CP068262.2", "NC_000016.10", "NC_060940.1"], "protein": ["AAC50348.1", "AAF01409.1", "AAH03512.1", "AAH09272.1", "AAK61253.1", "AAV87530.1", "BAA08419.1", "EAW85719.1", "EAW85720.1", "EAW85721.1", "NP_001170826.1", "NP_005814.2", "NP_037536.2", "Q13421.2"], "rna": ["AF180951.1", "AL545401.3", "AY743922.1", "BC003512.1", "BC009272.2", "CB266931.1", "D49441.1", "NM_001177355.3", "NM_005823.6", "NM_013404.4", "U40434.1"], "translation": [{"protein": "AAV87530.1", "rna": "AY743922.1"}, {"protein": "BAA08419.1", "rna": "D49441.1"}, {"protein": "AAC50348.1", "rna": "U40434.1"}, {"protein": "AAF01409.1", "rna": "AF180951.1"}, {"protein": "AAH09272.1", "rna": "BC009272.2"}, {"protein": "NP_001170826.1", "rna": "NM_001177355.3"}, {"protein": "AAH03512.1", "rna": "BC003512.1"}, {"protein": "NP_005814.2", "rna": "NM_005823.6"}, {"protein": "NP_037536.2", "rna": "NM_013404.4"}]}, "alias": ["MPF", "SMRP"], "ensembl": {"gene": "ENSG00000102854", "protein": ["ENSP00000372313", "ENSP00000442965", "ENSP00000454295", "ENSP00000456008", "ENSP00000456132", "ENSP00000456702", "ENSP00000457847", "ENSP00000458003"], "transcript": ["ENST00000382862", "ENST00000545450", "ENST00000561896", "ENST00000563651", "ENST00000563941", "ENST00000566269", "ENST00000566549", "ENST00000569566"], "translation": [{"protein": "ENSP00000442965", "rna": "ENST00000545450"}, {"protein": "ENSP00000456008", "rna": "ENST00000563941"}, {"protein": "ENSP00000456702", "rna": "ENST00000566549"}, {"protein": "ENSP00000372313", "rna": "ENST00000382862"}, {"protein": "ENSP00000456132", "rna": "ENST00000563651"}, {"protein": "ENSP00000458003", "rna": "ENST00000569566"}, {"protein": "ENSP00000454295", "rna": "ENST00000566269"}, {"protein": "ENSP00000457847", "rna": "ENST00000561896"}], "type_of_gene": "protein_coding"}, "entrezgene": "10232", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.0943052695, "exp_mis": 282.706941564, "exp_syn": 146.28229201, "lof_z": -0.195338971848972, "mis_z": -1.66667347223689, "mu_lof": 1.5256196227e-06, "mu_mis": 2.74895675919e-05, "mu_syn": 1.38946568906e-05, "n_lof": 22.0, "n_mis": 340.0, "n_syn": 185.0, "p_li": 2.47687992428564e-15, "p_null": 0.991479124367918, "p_rec": 0.00852087563207934, "syn_z": -1.98455475881924}, "bp": 1893, "cds_end": 818733, "cds_start": 812680, "n_exons": 16, "nonpsych": {"exp_lof": 18.8005173448, "exp_mis": 255.585205773, "exp_syn": 132.107727907, "lof_z": -0.0451827008904827, "mis_z": -2.06381080531864, "mu_lof": 1.5256196227e-06, "mu_mis": 2.74895675919e-05, "mu_syn": 1.38946568906e-05, "n_lof": 19.0, "n_mis": 321.0, "n_syn": 168.0, "p_li": 4.88092195732487e-13, "p_null": 0.975444443622751, "p_rec": 0.0245555563767606, "syn_z": -1.96607791041482}, "nontcga": {"exp_lof": 19.3783122657, "exp_mis": 260.061955955, "exp_syn": 134.551267193, "lof_z": -0.139314252124365, "mis_z": -1.60456377426646, "mu_lof": 1.5256196227e-06, "mu_mis": 2.74895675919e-05, "mu_syn": 1.38946568906e-05, "n_lof": 20.0, "n_mis": 312.0, "n_syn": 172.0, "p_li": 7.18803666533381e-14, "p_null": 0.983334082066443, "p_rec": 0.0166659179334852, "syn_z": -2.04416112912016}, "transcript": "ENST00000382862.3"}, "exons": [{"cdsend": 768733, "cdsstart": 762680, "chr": "16", "position": [[760733, 760821], [761132, 761174], [762671, 762765], [763232, 763276], [763641, 763691], [764022, 764143], [764646, 764726], [764906, 765036], [765109, 765303], [765526, 765617], [765690, 765790], [766058, 766237], [766334, 766490], [766667, 766810], [766884, 767012], [767375, 767470], [768378, 768565], [768647, 768862]], "strand": 1, "transcript": "NM_001177355", "txend": 768862, "txstart": 760733}, {"cdsend": 768733, "cdsstart": 762680, "chr": "16", "position": [[760733, 760821], [761072, 761174], [762671, 762765], [763232, 763276], [763641, 763691], [764022, 764143], [764646, 764726], [764906, 765036], [765109, 765303], [765526, 765617], [765690, 765790], [766058, 766237], [766334, 766490], [766667, 766810], [766884, 767012], [767375, 767470], [768378, 768565], [768647, 768862]], "strand": 1, "transcript": "NM_005823", "txend": 768862, "txstart": 760733}, {"cdsend": 768733, "cdsstart": 762680, "chr": "16", "position": [[761072, 761174], [762671, 762765], [763232, 763276], [763641, 763691], [764022, 764143], [764646, 764726], [764906, 765036], [765109, 765303], [765526, 765617], [765690, 765790], [766058, 766237], [766334, 766490], [766643, 766810], [766884, 767012], [767375, 767470], [768378, 768565], [768647, 768865]], "strand": 1, "transcript": "NM_013404", "txend": 768865, "txstart": 761072}], "exons_hg19": [{"cdsend": 818733, "cdsstart": 812680, "chr": "16", "position": [[810733, 810821], [811132, 811174], [812671, 812765], [813232, 813276], [813641, 813691], [814022, 814143], [814646, 814726], [814906, 815036], [815109, 815303], [815526, 815617], [815690, 815790], [816058, 816237], [816334, 816490], [816667, 816810], [816884, 817012], [817375, 817470], [818378, 818565], [818647, 818862]], "strand": 1, "transcript": "NM_001177355", "txend": 818862, "txstart": 810733}, {"cdsend": 818733, "cdsstart": 812680, "chr": "16", "position": [[810733, 810821], [811072, 811174], [812671, 812765], [813232, 813276], [813641, 813691], [814022, 814143], [814646, 814726], [814906, 815036], [815109, 815303], [815526, 815617], [815690, 815790], [816058, 816237], [816334, 816490], [816667, 816810], [816884, 817012], [817375, 817470], [818378, 818565], [818647, 818862]], "strand": 1, "transcript": "NM_005823", "txend": 818862, "txstart": 810733}, {"cdsend": 818733, "cdsstart": 812680, "chr": "16", "position": [[811072, 811174], [812671, 812765], [813232, 813276], [813641, 813691], [814022, 814143], [814646, 814726], [814906, 815036], [815109, 815303], [815526, 815617], [815690, 815790], [816058, 816237], [816334, 816490], [816643, 816810], [816884, 817012], [817375, 817470], [818378, 818565], [818647, 818865]], "strand": 1, "transcript": "NM_013404", "txend": 818865, "txstart": 811072}], "generif": [{"pubmed": 14676194, "text": "binding of membrane-bound mesothelin to ovarian cancer antigen CA125 mediates heterotypic cell adhesion"}, {"pubmed": 15217923, "text": "mesothelin is highly expressed in several human cancers [review]"}, {"pubmed": 16428485, "text": "Elevated serum mesothelin is associated with mesothelioma and ovarian cancer"}, {"pubmed": 16467095, "text": "The mesothelin expression is associated with prolonged survival in patients with high-grade ovarian serous carcinoma."}, {"pubmed": 16638849, "text": "MSLN, a tumor marker, is also used as a target for immunotherapy."}, {"pubmed": 16857795, "text": "MPF is secreted by several mesothelioma cell lines and is frequently elevated in the blood of patients with mesothelioma"}, {"pubmed": 17067392, "text": "Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors."}, {"pubmed": 17276942, "text": "Mesothelin was expressed in 5 (50%) of 10 adenocarcinomas, 1 (17%) of 6 high-grade dysphasia/adenocarcinoma in situ cases, and 0 low-grade dysplasia."}, {"pubmed": 17598982, "text": "We present evidence that during cell division the decreasing activity of MPF acts as a master signal, which utilizes different thresholds to control initiation of different mitotic events. The key temporal control here is the degradation of cyclin B1."}, {"pubmed": 17803679, "text": "Primary acute myeloid leukemia cells express mesothelin"}, {"pubmed": 18042078, "text": "an immunohistochemical panel including CK7,CD10 and mesothelin is optimal for distinguishing between ovarian and renal clear cell carcinoma."}, {"pubmed": 18064689, "text": "Mesothelin is not useful in the differential diagnosis of lung adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma."}, {"pubmed": 18154821, "text": "data support soluble mesothelin-related peptide as a promising marker for malignant pleural mesothelioma in both serum and pleural effusion fluid in asbestos-exposed cohorts"}, {"pubmed": 18167128, "text": "mesothelin expression,production in supernatants from epithelioid MPM cell lines"}, {"pubmed": 18245228, "text": "Overexpression of MSLN resulted in sustained activation of extracellular signal-regulated kinase 1/2 and suppression of Bim."}, {"pubmed": 18281122, "text": "expression in <50% of tumor cells is a negative prognostic marker in malignant mesothelioma"}, {"pubmed": 18281514, "text": "Novel functions of mesothelin and a new therapeutic vaccine strategy whereby mesothelin is targeted to control pancreatic cancer progression."}, {"pubmed": 18316566, "text": "Extremely high mesothelin levels were associated with mesothelioma"}, {"pubmed": 18347077, "text": "These findings suggest that mesothelin is expressed in at least some arachnoid and meningioma cells."}, {"pubmed": 18394747, "text": "diagnostic value of Megakaryocyte potentiating factor for malignant pleural mesothelioma was better than that of mesothelin although both markers showed almost equal specificity for MPM"}, {"pubmed": 18546615, "text": "Assays measuring SMRP in serum and other bodily fluids are likely to be clinically useful for patients with ovarian cancer."}, {"pubmed": 18670302, "text": "Elevated megakaryocyte potentiating factor serum levels are associated with malignant mesothelioma."}, {"pubmed": 18691948, "text": "Mesothelin expression was observed in 24/84 (29%) of invasive adenocarcinomas and in 5/34 (15%) lymph node metastases."}, {"pubmed": 18788634, "text": "Expression of MESO mRNA and protein is increased in ovarian carcinomas and borderline ovarian tumors."}, {"pubmed": 18978568, "text": "Significantly higher soluble mesothelin-related protein is associated with malignant pleural mesothelioma."}, {"pubmed": 19010822, "text": "data indicate overexpression of MSLN in pancreatic cancer cells leads to constitutive activation of Stat3, resulting in enhanced expression of cyclin E & cyclin E/cyclin-dependent kinase 2 complex formation & increased G(1)-S transition"}, {"pubmed": 19020717, "text": "analysis of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma"}, {"pubmed": 19075018, "text": "A binding domain on mesothelin for CA125/MUC16."}, {"pubmed": 19293794, "text": "higher mesothelin expression is associated with chemoresistance in patients and shorter patient survival."}, {"pubmed": 19747165, "text": "Data show that mesothelin is a potential target in reducing resistance to cytotoxic drugs, and mesothelin-treated cells revealed rapid tyrosine phosphorylation of the p85 subunit of PI3K."}, {"pubmed": 19858537, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19858537, "text": "Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein"}, {"pubmed": 20131968, "text": "SMRP is characterterized as a biomarker for malignant mesothelioma in human"}, {"pubmed": 20349783, "text": "A correlation was found between mesothelin expression and the average methylation/hypomethylation status as well as methylation/hypomethylation status at four of 20 CpG sites in ovarian samples. No correlation was found in endometrial samples"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20573372, "text": "Hypomethylation of the MSLN promoter may be specifically associated with the formation of malignant mesothelioma."}, {"pubmed": 20593939, "text": "Elevated levels of mesothelin is associated with ovarian carcinoma in patients with pelvic masses."}, {"pubmed": 20596597, "text": "Investigated whether N-ERC (the 30 kDa N-terminal secretory form of ERC/mesothelin) could function as a secretory factor to stimulate tumor progression."}, {"pubmed": 20943257, "text": "The mesothelin appeared in maturing epithelial cells and characterized nests of tumor cells."}, {"pubmed": 21288909, "text": "Data suggested that the cause of MSLN cancer-specific overexpression might also contribute mechanistically to the overexpression of other tumor markers."}, {"pubmed": 21333373, "text": "elevated serum levels is in individuals with renal impairment"}, {"pubmed": 21397972, "text": "elevated plasma levels in malignant mesothelioma patients"}, {"pubmed": 21483773, "text": "miR-126, in association with soluble mesothelin-related peptides, as a marker for early detection of malignant pleural mesothelioma"}, {"pubmed": 21508397, "text": "High mesothelin is associated with renal failure in mesothelioma."}, {"pubmed": 21515913, "text": "using a panel of PC cells with varying MSLN/IL-6 expressions, we showed that MSLN/IL-6 axis is a major survival axis in PC supporting tumor cell growth under anchorage-dependent and independent conditions"}, {"pubmed": 21538952, "text": "Use of S100P and mesothelin in cytologically borderline cases can increase the diagnostic accuracy for pancreatic adenocarcinoma."}, {"pubmed": 21574151, "text": "the aim of this study was to investigate the association between single nucleotide polymorphisms within the promoter-5'UTR regions and SMRP levels in healthy asbestos-exposed individuals and patients with malignant pleural mesothelioma."}, {"pubmed": 21632639, "text": "GPR30 is more sensitive, but less specific than mesothelin for pancreatic adenocarcinoma"}, {"pubmed": 21775819, "text": "These results demonstrate that MSLN is normally methylated in the pleura, and that methylation is lost in most tumors."}, {"pubmed": 21775916, "text": "Finding suggests that co-expression of mesothelin and CA125 plays a significant role in the acquisition of aggressive clinical behavior."}, {"pubmed": 21780126, "text": "High mesothelin is associated with gastric cancer."}, {"pubmed": 21841505, "text": "High mesothelin is associated with mesothelioma."}, {"pubmed": 21880146, "text": "Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt/PI3K/NF-kappa-B activation and IL-6/Mcl-1 overexpression"}, {"pubmed": 21999204, "text": "correlation between MSLN and MMP-7 in the progression of ovarian cancer, and the mechanism of MSLN in enhancing ovarian cancer invasion"}, {"pubmed": 22113177, "text": "In epithelioid mesotheliomas, 13% of cells expressed nestin, 39% EMA and 7% mesothelin"}, {"pubmed": 22149739, "text": "Serum mesothelin and MPF do not appear to be useful biomarkers for pancreatic and biliary cancers"}, {"pubmed": 22237988, "text": "High mesothelin is associated with Barrett's associated esophageal adenocarcinoma."}, {"pubmed": 22320398, "text": "we identified two specific genes, MUC16 and mesothelin, associated with the invasion process in patients with PDAC."}, {"pubmed": 22351743, "text": "Studies indicate that the limited expression of mesothelin on normal human tissues and its high expression in many common cancers make it an attractive candidate for cancer therapy."}, {"pubmed": 22371455, "text": "Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in epithelioid pleural mesothelioma patients."}, {"pubmed": 22377706, "text": "Soluble mesothelin-related peptides may be a useful tumor marker for detecting the progression of malignant mesothelioma and evaluating tumor response to treatment."}, {"pubmed": 22386954, "text": "Mesothelin levels in urine are affected by impaired glomerular and tubular function, which can influence the interpretation of mesothelin measurements and might cause false-positive resul"}, {"pubmed": 22412141, "text": "Review/Meta-Analysis: In patients suspected of having pleural mesothelioma, a positive blood test for mesothelin at a high-specificity threshold is a strong incentive to urge further diagnostic steps."}, {"pubmed": 22721387, "text": "The mesothelin expression promotes resistance to certain chemotherapy drugs such as TNF-alpha, paclitaxel, and a combination of platinum and cyclophosphamide."}, {"pubmed": 22729037, "text": "High SMRP is associated with mesothelioma in pleural effusions."}, {"pubmed": 22787150, "text": "structural and mechanistic analysis of recognition of mesothelin by the therapeutic antibody MORAb-009"}, {"pubmed": 22792233, "text": "MUC1 and MSLN were superior to pathologic features and other putative biomarkers as predicting survival group."}, {"pubmed": 22835614, "text": "Mesothelin, megakaryocyte potentiating factor and osteopontin are expressed in malignant mesothelioma [review]"}, {"pubmed": 23034174, "text": "Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway."}, {"pubmed": 23064529, "text": "the expression pattern level of mesothelin, i.e., in luminal membrane or cytoplasm both high and low level, evidently indicate the patient prognosis of extrahepatic bile duct cancer."}, {"pubmed": 23093275, "text": "poor sensitivity of SMRP found in this study suggests that further work is needed to find new candidate biomarkers for diagnosing early stage malignant mesothelioma"}, {"pubmed": 23225411, "text": "Most mesothelioma tumors loose mesothelin when grown in vitro and the sensitivity of these cells to SS1P is dependent on the number of mesothelin sites/cell."}, {"pubmed": 23249166, "text": "Soluble mesothelin-related peptide detection in MPM-PE can help the diagnosis of MPM."}, {"pubmed": 23267165, "text": "Mesothelin appears to correlate with clinical prognostic parameters and might be useful biomarkers for therapy monitoring and, thus, could serve as attractive targets for therapy of ovarian cancer"}, {"pubmed": 23277285, "text": "SMRP was lower in healthy subjects than in subjects with malignant tumors, asbestos-related pleural lesions, and other benign diseases"}, {"pubmed": 23321167, "text": "MSLN overexpression promoted the invasive potential of MCF-7 cells through ERK1/2-dependent upregulation of MMP-9; this association may have contributed to metastasis of MCF-7 cells in vivo."}, {"pubmed": 23357461, "text": "Data indicate that binding of mesothelin to CA125 does not alter the measurement of mesothelin for the detection of malignant mesothelioma (MM)."}, {"pubmed": 23512344, "text": "Mesothelin provokes lymphatic invasion of colorectal adenocarcinoma."}, {"pubmed": 23532816, "text": "SMRP could improve CYFRA 21-1 antigen and carcinoembryonic antigen (CEA) accuracy in the differential diagnosis of malignant pleural mesothelioma."}, {"pubmed": 23694968, "text": "Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation."}, {"pubmed": 23701154, "text": "Being negative/focally positive for mesothelin expression was associated with longer postoperative survival than positive expression in patients with cholangiocellular carcinoma. Mesothelin positivity was a predictor of short postoperative survival."}, {"pubmed": 23810431, "text": "Mesothelin expression was identified in 34% of patients with triple receptor negative breast cancer."}, {"pubmed": 23873013, "text": "PE-SMRP adds some clinical information in the work-up of patients with a PE of unknown origin."}, {"pubmed": 23991032, "text": "Data indicate that biochemical markers significantly associated with mesothelioma were hyaluronan, N-ERC/mesothelin and syndecan-1."}, {"pubmed": 24146039, "text": "In the gastric cancer tissues, C-ERC/mesothelin expression was associated with lymphatic invasion. N-ERC/mesothelin was secreted into the supernatants of gastric cancer cell lines, but does not appear to be a useful serum marker of gastric cancer."}, {"pubmed": 24308545, "text": "Serum IGFBP2 and MSLN are weak diagnostic classifiers individually, but may be useful in a diagnostic biomarker panel for pancreatic cancer."}, {"pubmed": 24324091, "text": "addition of YKL-40 may improve the specificity of mesothelin measurements alone for detecting patients with multiple myeloma"}, {"pubmed": 24334761, "text": "MSLN expression in patients with early-stage lung adenocarcinoma is associated with increased risk of recurrence and reduced overall survival."}, {"pubmed": 24344503, "text": "These data suggest that in difficult diagnostic cases both PAX2 and mesothelin immunohistochemical study may be useful in discriminating between PMRCC and primary pancreatic carcinoma."}, {"pubmed": 24465798, "text": "MSLN-silencing caused decreased proliferation rate and reduced invasive capacity and sphere formation in MSLN-overexpressing Mero-14 cells."}, {"pubmed": 24520352, "text": "These data provides evidence for the use of mesothelin as an immunogen for tumour-specific T cell response."}, {"pubmed": 25125620, "text": "Our findings suggest that MLSN can be used as a marker of neoplastic transformation of epithelial cells in pancreatic mucinous cysts."}, {"pubmed": 25193277, "text": "Mesothelin expression is associated with poor outcomes in breast cancer.Mesothelin is a prognostic breast tumor marker whose expression is highly enriched in triple negative breast cancer tumors."}, {"pubmed": 25197000, "text": "Both the serum CA125(meso) level and the ratio of the serum CA125(mesothelin) to CA125 levels (CA125(mesothelin) /CA125) were significantly higher in patients with EOC."}, {"pubmed": 25227779, "text": "A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice."}, {"pubmed": 25378643, "text": "Delivery of mesothelin-targeted CAR T cells eradicates tumors in mice with pleural malignancies."}, {"pubmed": 25436799, "text": "findings replicate association between rs1057147 and soluble mesothelin related peptide(SMRP)levels; SMRP performance as diagnostic biomarker for malignant pleural mesothelioma improved by considering genotype rs1057147; this polymorphism most likely affects a binding site for miR-611"}, {"pubmed": 25477701, "text": "Patients with colon cancer had significantly higher mesothelin serum levels than the control groups."}, {"pubmed": 25505814, "text": "Pleural fluid mesothelin may serve as a marker for pleural malignant mesothelioma."}, {"pubmed": 25506917, "text": "Patients with mesothelin-positive triple negative breast carcinomas (TNBC) were older than patients with mesothelin-negative TNBC, developed more distant metastases with a shorter interval, and had significantly lower overall and disease-free survival."}, {"pubmed": 25776500, "text": "Expression of mesothelin was observed in 42.3% of patients with triple negative breast cancer."}, {"pubmed": 26028668, "text": "High mesothelin expression was strongly associated with mutant KRAS/wild-type EGFR and poor prognosis in advanced lung cancer."}, {"pubmed": 26172299, "text": "Data indicate that triple-negative breast cancer (TNBC) showed the highest amplification rate (42%) in the basal-like 1 subtype."}, {"pubmed": 26188910, "text": "There was a trend toward elevation of SMRP values in healthy individuals exposed to asbestos compared to those without exposure. Within asbestosis cases, those with higher profusion scores had higher SMRP values than those with lower profusion scores."}, {"pubmed": 26536664, "text": "Results indicate a specific mesothelin-driven tumor uptake of targeted 89zirconium-labeled antibody which visualizes mesothelin expressing pancreatic cancer in real time."}, {"pubmed": 26874572, "text": "Our results showed that IMP3 immunostaining has a higher sensitivity and specificity than mesothelin for the diagnosis of pancreatic ductal adenocarcinoma. IMP3 and mesothelin may be useful markers in distinguishing neoplastic from reactive lesions of the pancreas in instances where this is impossible by morphology alone in surgical pathology practice."}, {"pubmed": 27062033, "text": "Calretinin, D2-40 and mesothelin are aberrantly expressed in a proportion of CRC cases."}, {"pubmed": 27422997, "text": "MSLN expression increases cell migration and invasion in vitro."}, {"pubmed": 27635089, "text": "RG7787 plus nab-paclitaxel is very active against primary human mesothelioma cells in vitro as well as in vivo, with serum mesothelin levels correlating with tumor response. These results indicate that this combination could be useful for treating patients with mesothelioma"}, {"pubmed": 27646775, "text": "High mesothelin expression is associated with malignant pleural mesothelioma."}, {"pubmed": 27999204, "text": "Mesothelin-targeted immunotoxin RG7787 increases pancreatic cancer cell sensitivity to taxane-mediated killing by increasing taxane-mediated microtubule stability and priming cells for apoptosis by decreasing levels of the pro-survival factor Mcl-1."}, {"pubmed": 28125734, "text": "MiR-21-5p is suggested as novel regulator of MSLN with a possible functional role in cellular growth."}, {"pubmed": 28160193, "text": "we report herein that high tumor mesothelin expression predicts a shorter PFS and OS in EOC patients and demonstrates that serum mesothelin predicts local tumor mesothelin expression."}, {"pubmed": 28287406, "text": "Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis.("}, {"pubmed": 28288645, "text": "We provide new evidence for the role of MSLN in EMT regulation, tumorigenesis and metastasis. Knockdown of MSLN led to mesenchymal to epithelial transition and less aggressive behavior of lung carcinoma and mesothelioma cells."}, {"pubmed": 28314308, "text": "SMRP but not FBLN3 has a role in pleural effusions in in malignant pleural mesothelioma"}, {"pubmed": 28674083, "text": "Our goal was to stimulate antitumor immunity by combining SS1P or LMB-100 with anti-CTLA-4. We constructed a BALB/c breast cancer cell line expressing human mesothelin (66C14-M), which was implanted in one or two locations. SS1P or LMB-100 was injected directly into established tumors and anti-CTLA-4 administered i.p. In mice with two tumors, one tumor was injected with immunotoxin and the other was not."}, {"pubmed": 28929447, "text": "Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells."}, {"pubmed": 29334771, "text": "In a murine ovarian cancer model, a single intraperitoneal injection of CARMA-hMeso resulted in the dose-dependent inhibition of tumor growth and improved survival of mice. Furthermore, repeat weekly intraperitoneal administrations of the optimal CARMA-hMeso dose further prolonged disease control and survival. No significant off-target toxicities were observed"}, {"pubmed": 29454314, "text": "We have demonstrated that a rising serum mesothelin is a sensitive marker of progression in the follow up of patients with MPM."}, {"pubmed": 29738555, "text": "we engineered variants of the fibronectin type III domain (Fn3) non-antibody protein scaffold to bind to mesothelin with high affinity, using directed evolution and yeast surface display"}, {"pubmed": 30260046, "text": "inspection showed that MSLN (Mesothelin), ANTXR1 (TEM8), and MUC3A are the probable targets of CAR T cell therapy in gastric adenocarcinoma."}, {"pubmed": 30319054, "text": "Elevated plasma MSLN level is related with epithelial ovarian cancer."}, {"pubmed": 30370398, "text": "in cohorts of mesothelioma and lung cancer patients, increased MPF was a predictor of poor survival"}, {"pubmed": 30583024, "text": "Results found that MESO protein was highly expressed in the cervical squamous cell carcinoma. When MSLN was knocked down in SiHa cells, cell apoptosis increased, but no significant effects were observed on cell proliferation and migration. Thus, the study shows that MSLN plays a role in the apoptosis of cervical squamous cell carcinoma cells."}, {"pubmed": 30603773, "text": "Immunohistochemical evaluation of MSLN expression was helpful in the prediction of patient prognosis in stage II/III colorectal carcinoma."}, {"pubmed": 31169881, "text": "32 studies with mesothelin levels were included in the META-ANALYSIS. Statistically significant mean differences were seen between malignant pleural mesothelioma (MPM) patients and all other comparison groups for mesothelin blood and pleural levels."}, {"pubmed": 31267149, "text": "Mesothelin, calretinin, and megakaryocyte potentiating factor showed a good performance in a Mestizo-Mexican population, with high sensitivity and specificity for the diagnosis of malignant pleural mesothelioma."}, {"pubmed": 31537838, "text": "Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer."}, {"pubmed": 32143496, "text": "A Novel T Cell-Engaging Bispecific Antibody for Treating Mesothelin-Positive Solid Tumors."}, {"pubmed": 32187018, "text": "Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases."}, {"pubmed": 32468249, "text": "Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma."}, {"pubmed": 32677949, "text": "Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression."}, {"pubmed": 32997381, "text": "Association of genetic variants in the 3'-untranslated region of the mesothelin (MSLN) gene with ovarian carcinoma."}, {"pubmed": 33262421, "text": "Multiple proteases are involved in mesothelin shedding by cancer cells."}, {"pubmed": 33373818, "text": "The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth."}, {"pubmed": 33476708, "text": "Furin is not required for processing of mesothelin precursor protein."}, {"pubmed": 33613114, "text": "Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway."}, {"pubmed": 33832498, "text": "Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis."}, {"pubmed": 34143695, "text": "Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness."}, {"pubmed": 34325726, "text": "IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin."}, {"pubmed": 34673000, "text": "Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo."}, {"pubmed": 34830322, "text": "Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment."}, {"pubmed": 35162954, "text": "Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer."}, {"pubmed": 35340746, "text": "Effects of hsa-mir-145-5p on the Regulation of msln Expression in Colorectal Adenocarcinoma."}, {"pubmed": 37040900, "text": "High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma."}, {"pubmed": 37775021, "text": "Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression."}, {"pubmed": 37914528, "text": "Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression."}, {"pubmed": 38227666, "text": "Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope."}, {"pubmed": 38396817, "text": "Enhanced Expression of Glycolytic Enzymes and Succinate Dehydrogenase Complex Flavoprotein Subunit A by Mesothelin Promotes Glycolysis and Mitochondrial Respiration in Myeloblasts of Acute Myeloid Leukemia."}, {"pubmed": 38637885, "text": "Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer."}], "genomic_pos": {"chr": "16", "end": 768865, "ensemblgene": "ENSG00000102854", "start": 760734, "strand": 1}, "genomic_pos_hg19": {"chr": "16", "end": 818865, "start": 810762, "strand": 1}, "go": {"BP": [{"evidence": "NAS", "gocategory": "BP", "id": "GO:0007155", "pubmed": 8552591, "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007160", "qualifier": "involved_in", "term": "cell-matrix adhesion"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005794", "qualifier": "located_in", "term": "Golgi apparatus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "is_active_in", "term": "cell surface"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 8552591, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098552", "qualifier": "located_in", "term": "side of membrane"}], "MF": {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 14676194, "qualifier": "enables", "term": "protein binding"}}, "homologene": {"genes": [[8364, 100489413], [8364, 101733470], [9031, 416534], [9544, 698095], [9598, 453806], [9606, 10232], [9615, 611363], [9913, 516237], [10090, 56047], [10116, 60333]], "id": 4249}, "interpro": [{"desc": "Mesothelin", "id": "IPR010335", "short_desc": "Mesothelin"}, {"desc": "Stereocilin-related", "id": "IPR026664", "short_desc": "Stereocilin-rel"}], "ipi": ["IPI00025110", "IPI00793522", "IPI00793649", "IPI00798210"], "map_location": "16p13.3", "name": "mesothelin", "other_names": ["CAK1 antigen", "megakaryocyte potentiating factor", "mesothelin", "pre-pro-megakaryocyte-potentiating factor", "soluble MPF mesothelin related protein"], "pantherdb": {"HGNC": "7371", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1888992", "ortholog_type": "LDO", "panther_family": "PTHR23412", "taxid": 10090, "uniprot_kb": "Q61468"}, {"RGD": "69333", "ortholog_type": "LDO", "panther_family": "PTHR23412", "taxid": 10116, "uniprot_kb": "Q9ERA7"}, {"Ensembl": "ENSGALG00000005349", "ortholog_type": "LDO", "panther_family": "PTHR23412", "taxid": 9031, "uniprot_kb": "F1NZV7"}, {"ZFIN": "ZDB-GENE-120727-9", "ortholog_type": "O", "panther_family": "PTHR23412", "taxid": 7955, "uniprot_kb": "A0A0R4IDJ5"}, {"ZFIN": "ZDB-GENE-121214-355", "ortholog_type": "LDO", "panther_family": "PTHR23412", "taxid": 7955, "uniprot_kb": "A0A0R4IDN9"}, {"Ensembl": "ENSDARG00000100739", "ortholog_type": "LDO", "panther_family": "PTHR23412", "taxid": 7955, "uniprot_kb": "A0A0G2KXH3"}], "uniprot_kb": "Q13421"}, "pathway": {"reactome": [{"id": "R-HSA-163125", "name": "Post-translational modification: synthesis of GPI-anchored proteins"}, {"id": "R-HSA-381426", "name": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-8957275", "name": "Post-translational protein phosphorylation"}]}, "pdb": ["4F3F", "7U8C", "7U9J", "7UED", "8CX3", "8CXC", "8CYH", "8CZ8"], "pfam": "PF06060", "pharmgkb": "PA31176", "pharos": {"target_id": 3645, "tdl": "Tbio"}, "reagent": {"CondMedia_CM_LibrAB": {"id": "GNF292737", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF261231", "relationship": "is"}, {"id": "GNF261232", "relationship": "is"}, {"id": "GNF261233", "relationship": "is"}, {"id": "GNF261234", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163265", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF047689", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF085944", "relationship": "is"}, {"id": "GNF085945", "relationship": "is"}, {"id": "GNF085946", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051998", "relationship": "is"}, {"id": "GNF056764", "relationship": "is"}, {"id": "GNF061567", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066031", "relationship": "is"}, {"id": "GNF066032", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF009964", "relationship": "is"}, {"id": "GNF009965", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": [{"id": "GNF336077", "relationship": "is"}, {"id": "GNF338956", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF111391", "relationship": "is"}, {"id": "GNF151032", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1"], "protein": ["NP_001170826.1", "NP_005814.2", "NP_037536.2"], "rna": ["NM_001177355.3", "NM_005823.6", "NM_013404.4"], "translation": [{"protein": "NP_001170826.1", "rna": "NM_001177355.3"}, {"protein": "NP_005814.2", "rna": "NM_005823.6"}, {"protein": "NP_037536.2", "rna": "NM_013404.4"}]}, "reporter": {"HG-U133_Plus_2": "204885_s_at", "HG-U95Av2": "32072_at", "HTA-2_0": ["TC16000022.hg.1", "TC16001373.hg.1"], "HuEx-1_0": "3643396", "HuGene-1_1": "7992071", "HuGene-2_1": "16814366"}, "summary": "This gene encodes a preproprotein that is proteolytically processed to generate two protein products, megakaryocyte potentiating factor and mesothelin. Megakaryocyte potentiating factor functions as a cytokine that can stimulate colony formation of bone marrow megakaryocytes. Mesothelin is a glycosylphosphatidylinositol-anchored cell-surface protein that may function as a cell adhesion protein. This protein is overexpressed in epithelial mesotheliomas, ovarian cancers and in specific squamous cell carcinomas. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016].", "symbol": "MSLN", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334533"}, "unigene": "Hs.408488", "uniprot": {"Swiss-Prot": "Q13421", "TrEMBL": ["H3BUX1", "H3BMA1", "H3BR90", "H3BV92"]}, "wikipedia": {"url_stub": "Mesothelin"}}